Imaging of the prostate

[1]  Osamu Ukimura,et al.  A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. , 2016, European urology.

[2]  M. Stifelman,et al.  A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy. , 2016, Urologic oncology.

[3]  Valentina Taviani,et al.  Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer , 2015, The Journal of Nuclear Medicine.

[4]  M. Wirth,et al.  Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer , 2015, BJU international.

[5]  J. Fettich,et al.  The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer , 2015, Abdominal Imaging.

[6]  M. Wirth,et al.  Multiparametric Prostate Magnetic Resonance Imaging at 3 T: Failure of Magnetic Resonance Spectroscopy to Provide Added Value , 2015, Journal of computer assisted tomography.

[7]  T. H. van der Kwast,et al.  Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer , 2015, World Journal of Urology.

[8]  P. Choyke,et al.  Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance. , 2015, Urologic oncology.

[9]  M. Schwaiger,et al.  Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy , 2015, The Journal of Nuclear Medicine.

[10]  A. Villers,et al.  Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. , 2015, European urology.

[11]  S. Davis,et al.  Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer , 2015, Prostate Cancer and Prostatic Disease.

[12]  M. Gross,et al.  Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies , 2015, World Journal of Urology.

[13]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[14]  Pierre Mozer,et al.  First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography‐guided biopsies for the diagnosis of localised prostate cancer , 2015, BJU international.

[15]  C. Catalano,et al.  Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. , 2015, Urologic oncology.

[16]  M. H. Poulsen,et al.  Spine metastases in prostate cancer: comparison of technetium‐99m‐MDP whole‐body bone scintigraphy, [18F]choline positron emission tomography(PET)/computed tomography (CT) and [18F]NaF PET/CT , 2014, BJU international.

[17]  P. Albers,et al.  Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen. , 2014, The Journal of urology.

[18]  M. Stifelman,et al.  A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. , 2014, European urology.

[19]  F. Schröder,et al.  Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.

[20]  Baris Turkbey,et al.  Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. , 2014, The Journal of urology.

[21]  Shyam Natarajan,et al.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.

[22]  Nicholas G Zaorsky,et al.  A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. , 2014, Future oncology.

[23]  Adam T Froemming,et al.  Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of 11C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil , 2014, The Journal of Nuclear Medicine.

[24]  Jurgen J Fütterer,et al.  Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. , 2014, AJR. American journal of roentgenology.

[25]  A. Kopp-Schneider,et al.  Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  S. Eggener,et al.  Development and multi‐institutional validation of an upgrading risk tool for Gleason 6 prostate cancer , 2013, Cancer.

[27]  Baris Turkbey,et al.  Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. , 2013, European urology.

[28]  Heinz-Peter Schlemmer,et al.  Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. , 2013, The Journal of urology.

[29]  Jan van der Meulen,et al.  Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. , 2013, Radiology.

[30]  P. Choyke,et al.  Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer , 2013, Cancer.

[31]  Xavier Leroy,et al.  Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. , 2013, Radiology.

[32]  D. Beyersdorff,et al.  MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies. , 2013, Diagnostic and interventional radiology.

[33]  Ivan Pedrosa,et al.  Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies. , 2013, Magnetic resonance imaging.

[34]  Gaelle Fiard,et al.  Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. , 2013, Urology.

[35]  Lalit Kumar,et al.  The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan , 2013, Japanese Journal of Radiology.

[36]  Naira Muradyan,et al.  Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. , 2013, The Journal of urology.

[37]  Mark Emberton,et al.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.

[38]  P. Mozer,et al.  Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. , 2012, European urology.

[39]  F. Beuvon,et al.  [Prebiopsy multiparametric MRI of the prostate: the end of randomized biopsies?]. , 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[40]  Eduard Baco,et al.  MRI and ultrasound-guided prostate biopsy using soft image fusion. , 2012, Anticancer research.

[41]  M. Kattan,et al.  Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer , 2012, BJU international.

[42]  C. Catalano,et al.  Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). , 2012, European journal of radiology.

[43]  E. Mittra,et al.  Prospective Evaluation of 99mTc MDP Scintigraphy, 18F NaF PET/CT, and 18F FDG PET/CT for Detection of Skeletal Metastases , 2012, Molecular Imaging and Biology.

[44]  R. Cohen,et al.  A new preoperative nomogram to predict minimal prostate cancer: accuracy and error rates compared to other tools to select patients for active surveillance. , 2011, The Journal of urology.

[45]  B. K. Park,et al.  Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. , 2011, AJR. American journal of roentgenology.

[46]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[47]  Michael Souvatzoglou,et al.  Radionuclide and hybrid imaging of recurrent prostate cancer. , 2011, The Lancet. Oncology.

[48]  J. Aerts,et al.  18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers , 2008, Nuclear medicine communications.

[49]  Tsuyoshi Mitake,et al.  Real‐time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data , 2010, International journal of urology : official journal of the Japanese Urological Association.

[50]  D. Gillatt,et al.  A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[51]  V. Bettinardi,et al.  Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[52]  F. Mottaghy,et al.  [11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy , 2009, World Journal of Urology.

[53]  B. K. Park,et al.  Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy , 2008, Investigative radiology.

[54]  A. Haese*,et al.  Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men , 2008, Cancer.

[55]  Daniele Regge,et al.  Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high‐intensity focused ultrasound , 2008, BJU international.

[56]  P. Troncoso,et al.  A nomogram for predicting low‐volume/low‐grade prostate cancer , 2007, Cancer.

[57]  H. Zaidi,et al.  18F‐choline and/or 11C‐acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate‐specific antigen values (<1 ng/mL) after radical prostatectomy , 2007, BJU international.

[58]  M. Kattan,et al.  The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis , 2007, BJU international.

[59]  E W Steyerberg,et al.  Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. , 2006, The Journal of urology.

[60]  G. Glatting,et al.  [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[61]  U. Metser,et al.  The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[62]  Hartwig Huland,et al.  Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. , 2003, The Journal of urology.

[63]  C C Schulman,et al.  Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? , 2001, The Journal of urology.

[64]  T. Block,et al.  Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical Prostatectomy , 1999, European Urology.

[65]  W. Catalona,et al.  Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.